![Per-Oluf Olsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Per-Oluf Olsen
Direttore/Membro del Consiglio presso Nextera AS
Profilo
Per-Oluf Olsen is currently the Director at Nextera AS and Co-Investor & External Partner at Birk Venture AS.
Previously, he was the Chief Executive Officer at Pronova BioPharma ASA from 2008 to 2009.
He also held positions as Principal at Rikshospitalet HF and Country Manager at Pfizer AS.
Mr. Olsen obtained an undergraduate degree from BI Norwegian Business School.
Posizioni attive di Per-Oluf Olsen
Società | Posizione | Inizio |
---|---|---|
Birk Venture AS
![]() Birk Venture AS Investment ManagersFinance Birk Venture AS (Birk Venture) is an independent Scandinavian venture capital firm which was founded in 2010 by Hans Ivar Robinson. Based in Oslo, Norway, the firm focuses exclusively on the life science industry, utilizing their industry experience and international network to partner with young companies with significant growth prospects. | Investitore di Private Equity | 01/03/2010 |
Nextera AS
![]() Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Direttore/Membro del Consiglio | 01/01/2010 |
Precedenti posizioni note di Per-Oluf Olsen
Società | Posizione | Fine |
---|---|---|
Pronova BioPharma ASA
![]() Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Amministratore Delegato | 01/07/2009 |
Rikshospitalet HF
![]() Rikshospitalet HF Hospital/Nursing ManagementHealth Services Rikshospitalet HF operates hospitals and healthcare centers. The private company is based in Oslo, Norway. | Corporate Officer/Principal | - |
Pfizer AS
![]() Pfizer AS Pharmaceuticals: MajorHealth Technology Pfizer AS operates as biopharmaceutical company, which engages in the development and manufacture of pharmaceutical products. It develops and produces medicines such as penicillin; vaccines; and medicines for the treatment of cancer, pain, cardiovascular disease, diabetes, mental illness, and rheumatism. The firm also offers drugs against parasites. The company was founded on November 25, 1959 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
Formazione di Per-Oluf Olsen
BI Norwegian Business School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Pronova BioPharma ASA
![]() Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
Nextera AS
![]() Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Commercial Services |
Pfizer AS
![]() Pfizer AS Pharmaceuticals: MajorHealth Technology Pfizer AS operates as biopharmaceutical company, which engages in the development and manufacture of pharmaceutical products. It develops and produces medicines such as penicillin; vaccines; and medicines for the treatment of cancer, pain, cardiovascular disease, diabetes, mental illness, and rheumatism. The firm also offers drugs against parasites. The company was founded on November 25, 1959 and is headquartered in Oslo, Norway. | Health Technology |
Birk Venture AS
![]() Birk Venture AS Investment ManagersFinance Birk Venture AS (Birk Venture) is an independent Scandinavian venture capital firm which was founded in 2010 by Hans Ivar Robinson. Based in Oslo, Norway, the firm focuses exclusively on the life science industry, utilizing their industry experience and international network to partner with young companies with significant growth prospects. | Finance |
Rikshospitalet HF
![]() Rikshospitalet HF Hospital/Nursing ManagementHealth Services Rikshospitalet HF operates hospitals and healthcare centers. The private company is based in Oslo, Norway. | Health Services |
- Borsa valori
- Insiders
- Per-Oluf Olsen